TAVI: prediction and prevention of complications

Session comprising selected PCR London Valves 2017 abstract submissions

Chairpersons: J. Byrne, A. Witkowski

Presentations available when logged in:

  • The impact of calcium burden on clinical outcomes and paravalvular regurgitation in the REPRISE III randomised controlled clinical trial
  • RenalGuard for prevention of acute kidney injury after TAVI in patients with severe aortic valve stenosis: first results of an ongoing study
  • Valve durability five years post-TAVI in a single-tertiary-centre
  • The impact of over-sizing transcatheter heart valve deployment for silent cerebral infarction after transfemoral aortic valve implantation
  • Bicuspid aortic valves anatomy and relationship with devices: the BAVARD multicentre registry